1,059
Views
25
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Health Effects of Using Cannabis for Therapeutic Purposes: A Gender Analysis of Users’ Perspectives

, , , , , , & show all
Pages 769-780 | Published online: 07 Dec 2010

REFERENCES

  • Amar, M. B. (2006). Cannabinoids in medicine: A review of their therapeutic potential. Journal of Ethnopharmacology, 105, 1–25.
  • Aryana, A., & Williams, M. A. (2007). Marijuana as a trigger for cardiac events: Speculation or scientific certainty. International Journal of Cardiology, 118(2), 141–144.
  • Ashton, C. H., Moore, P. B., Gallagher, P., & Young, A. H. (2005). Cannabinoids in bipolar affective disorder: A review and discussion of their therapeutic potential. Journal of Psychopharmacology, 19(3), 293–300.
  • Beal, J. E., Olson, R., Laubenstein, L., Morales, J. O., Bellman, P., Yangco, B., (1995). Dronabinol as a treatment for anorexia associated with weight loss in patients with AIDS. Journal of Pain & Symptom Management, 10, 89–97.
  • Belle-Isle, L., & Hathaway, A. (2007). Barriers to access to medical cannabis for Canadians living with HIV/AIDS. AIDS Care, 19(4), 500–506.
  • Bird, C. E., & Rieker, P. P. (1999). Gender matters: An integrated model for understanding men's and women's health. Social Science and Medicine, 48(6), 745–755.
  • Blake, D. R., Robson, P., Ho, M., Jubb, R. W., & McCabe, C. S. (2006). Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis. Reumatology, 45, 50–52.
  • Braitstein, P., Kendall, T., Chan, K., Wood, E., Montaner, J. S. G., O’Shaughnessy, (2001). Mary Jane and her patients: Sociodemographic and clinical characteristics of HIV-positive individuals using medical marijuana and antiretroviral agents. AIDS, 15(4), 532–533.
  • Branney, P., & White, A. (2008). Big boys don't cry: Depression and men. Advances in Psychiatric Treatment, 14, 256–262.
  • Budney, A. J., Hughes, J. R., Moore, B. A., & Vandrey, R. (2004). Review of the validity and significance of cannabis withdrawal syndrome. American Journal of Psychiatry, 161, 1967–1977.
  • Butters, J. E. (2004). The impact of peers and social disapproval on high-risk cannabis use: Gender differences and implications for drug education. Drugs: Education, Prevention, and Policy, 11(5), 381–390.
  • Canadian Medical Protective Association. (2001). Marijuana for medical reasons—The medical declaration form: An article for physicians by physicians. Retrieved April 2, 2010, from the World Wide Web: https: //www.cmpaacpm.ca/cmpapd04/docs/resource_files/infosheets/2009/com_is09103-e.cfm
  • Capler, R., & Lucas, P. (2006). Guidelines for the community-based distribution of medical cannabis in Canada. British Columbia Compassion Club Society and Vancouver Island Compassion Society. Retrieved August 20, 2009, from the World Wide Web: http://thevics.com/PDF/medcan_guidelines.pdf
  • Charmaz, K. (1995). Identity, dilemmas of chronically ill men. In D. Sabo & D. F. Gordon (Eds.), Men's health and illness: Gender, power and the body (pp. 269–288). Thousand Oaks, CA: Sage Publications.
  • Clark, A. J., Ware, M., Yazer, E., Murray, T. J., & Lynch, M. E. (2003). Patterns of cannabis use among patients with multiple sclerosis. Neurology, 62, 2098–2100.
  • Coggans, N., Dalgarno, P., Johnson, L., & Shewan, D. (2004). Long-term heavy cannabis use: Implications for health education. Drugs: Education, Prevention, and Policy, 11(4), 299–313.
  • College of Physicians and Surgeons of British Columbia. (2009). Resource manual—Marijuana for medical purposes. Retrieved February 15, 2010, from the World Wide Web: https://www.cpsbc.ca/files/u6/Marijuana-for-Medical-Purposes.pdf
  • Coomber, R., Oliver, M., & Morris, C. (2003). Using cannabis therapeutically in the UK: A qualitative analysis. Journal of Drug Issues, 33, 325–356.
  • Courtenay, W. H. (2000). Constructions of masculinity and their influence on men's well-being: A theory of gender and health. Social Science and Medicine, 50, 1385–1401.
  • Croxford, J. L. (2003). Therapeutic potential of cannabinoids in CNS disease. CNS Drugs, 17(3), 179–202.
  • Degenhardt, L., Hall, W., & Lynskey, M. (2003). Testing hypotheses about the relationship between cannabis use and psychosis. Drug and Alcohol Dependence, 71(1), 37–48.
  • de Jong, B. C., Prentiss, D., McFarland, W., Machekano, R., & Israelski, D. M. (2005). Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. Journal of Acquired Immune Deficiency Syndrome, 38(1), 43–46.
  • Eubanks, L. M., Rogers, C. J., Beuscher, A. E., Koob, G. F., Olson, A. J., Dickerson, T. J., (2006). A molecular link between the active component of marijuana and Alzheimer's disease pathology. Molecular Pharmaceutics, 3(6), 773–777.
  • Fischer, B., Reimer, J., Firestone, M., Kalousek, K., Rehm, J., & Heathcote, J. (2006). Treatment for hepatitis C virus and cannabis use in illicit drug user patients: Implications and questions. European Journal of Gastroenterology & Hepatology, 18, 1039–1042.
  • Furler, M. D., Einarson, T. R., Millson, M., Walmsley, S., & Bendayan, R. (2004). Medicinal and recreational marijuana use by patients infected with HIV. AIDS Patient Care and STDs, 18(4), 215–228.
  • Galdas, P. M., Cheater, F., & Marshall, P. (2005). Men and health help-seeking behaviour: Literature review. Journal of Advanced Nursing, 49, 616–623.
  • Hall, W., Degenhardt, L., & Teesson, M. (2004). Cannabis use and psychotic disorders: An update. Drug and Alcohol Review, 23, 433–443.
  • Harris, D., Jones, R. T., Shank, R., Nath, R., Fernandez, E., Goldstein, K., (2000). Self-reported marijuana effects and characteristics of 100 San Francisco medical marijuana club members. Journal of Addictive Diseases, 19(3), 89–103.
  • Health Canada. (2003). Information for health care professionals (revised)—Marihuana. Retrieved February 15, 2010, from the World Wide Web: http://www.hc-sc.gc.ca/dhp-mps/alt_formats/hecs-sesc/pdf/marihuana/how-comment/medpract/infoprof/m- arihuana-eng.pdf
  • Health Canada. (2005). Fact sheet—Medical access to marihuana. Retrieved February 15, 2010, from the World Wide Web: http://www.hc-sc.gc.ca/dhp-mps/marihuana/law-loi/fact_sheet-infofiche-eng.php
  • Health Canada. (2010). Health Canada statement on medical marihuana compassion clubs. Ottawa, ON: Health Canada. Retrieved July 13, 2010, from the World Wide Web: http://www.library.cornell.edu/resrch/citmanage/apa
  • Howard, J., Kofi, A. A., Holdcroft, A., Korn, S., & Davies, S. C. (2005). Cannabis use in sickle cell disease: A questionnaire study. British Journal of Haematology, 131, 123–128.
  • Howson, R. (2006). Challenging hegemonic masculinity. London, NY: Routledge.
  • Johnson, J., Greaves, L., & Repta, R. (2009). Better science with sex and gender: Facilitating the use of a sex and gender-based analysis in health research. International Journal for Equity in Health, 8(14). R etrieved June 15, 2010, from the World Wide Web: http://www.equityhealthj.com/content/pdf/1475-9276-8-14.pdf
  • Lee, C., & Owens, R. (2002). The psychology of men's health series. Philadelphia, PA: Open University Press.
  • Lincoln, Y. S., & Guba, E. G. (1985). Naturalistic inquiry. Newbury Park, CA: Sage Publications.
  • Lombardi, E. (2001). Enhancing transgender health care. American Journal of Public Health, 91(6), 869–872.
  • Lucas, P. G. (2008). Regulating compassion: An overview of Canada's federal medical cannabis policy and practice. Harm Reduction Journal, 5(5). Retrieved June 15, 2009, from the World Wide Web: http://www.harmreductionjournal.com/content/5/1/5
  • Lyons, A. C. (2009). Masculinities, femininities, behaviour and health. Social and Personality Compass, 3–4, 394–412.
  • McLaren, J. A., Silins, E., Hutchinson, D., Mattick, R. P., & Hall, W. (2010). Assessing evidence for a causal link between cannabis and psychosis: A review of cohort studies. International Journal of Drug Policy, 21(1), 10–19.
  • Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., (2007). Cannabis use and risk of psychotic or affective mental health outcomes: A systematic review. The Lancet, 370(9584), 319–328.
  • Ogborne, A. C., & Smart, R. G. (2000). Cannabis users in the general Canadian population. Substance Use & Misuse, 35, 301–311.
  • Ogborne, A. C., Smart, R. G., & Adlaf, E. M. (2000). Self-reported medical use of marijuana: A survey of the general population. Canadian Medical Association Journal, 162(12), 1685–1686.
  • Oliffe, J. L., & Phillips, M. J. (2008). Men, depression and masculinities: A review and recommendations. Journal of Men's Health, 5(3), 194–202.
  • Page, S. A., & Verhoef, M. J. (2006). Medicinal marijuana use: Experiences of people with multiple sclerosis. Canadian Family Physician, 52, 64–72.
  • Page, S. A., Verhoef, M. J., Stebbins, R. A., Metz, L. M., & Levy, J. C. (2003). Cannabis use as described by people with multiple sclerosis. Canadian Journal of Neurological Sciences, 30, 201–205.
  • Patton, D., & Adlaf, E. M. (2005). Cannabis use and problems. In E. M. Adlaf, P. Begin, & E. Sawka (Eds.), Canadian Addiction Survey (CAS): A national survey of Canadians’ use of alcohol and other drugs: Prevalence of use and related harms: Detailed report. Ottawa, ON: Canadian Centre on Substance Abuse.
  • Prentiss, D., Power, R., Balmas, G., Tzuang, G., & Israelski, D. M. (2004). Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. Journal of Acquired Immune Deficiency Syndrome, 35(1), 38–45.
  • Quebec compassion club users turn to black market. (2010, June 8). CBC News. Retrieved June 15, 2010, from the World Wide Web: http://www.cbc.ca/health/story/2010/06/08/mtl-quebec-medical-marijuana-black-market.html
  • Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6(35). Retrieved June 15, 2010, from the World Wide Web: http://www.harmreductionjournal/content/6/1/35
  • Rodondi, N., Pletcher, M. J., Liu, K., Hulley, S. B., & Sidney, S. (2006). Marijuana use, diet, BMI and cardiovascular risk factors (from the CARDIA study). American Journal of Cardiology, 98, 478–484.
  • Schippers, M. (2007). Recovering the feminine other: Masculinity, femininity, and gender hegemony. Theory & Society, 36, 85–102.
  • Sherrill, D. L. (1991). Respiratory effects of non-tobacco cigarettes: A longitudinal study in the general population. International Journal of Epidemiology, 20, 132–137.
  • Smith, N. T. (2002). A review of the published literature into cannabis withdrawal symptoms in human users. Addiction, 97, 621–632.
  • Soellner, R. (2005). Dependence on cannabis—an ever-lasting issue. Substance Use and Misuse, 40, 857–867.
  • Stockwell, T., Sturge, J., Jones, W., Fischer, B., & Carter, C. (2006). Cannabis use in British Columbia: Patterns of use, perceptions, and public opinion as assessed in the 2004 Canadian Addiction Survey. Victoria, BC: Centre for Addictions Research of BC British Columbia (CARBC). Retrieved August 9, 2009, from the World Wide Web: http://carbc.ca/portals/0/resources/CannabisUse0609.pdf
  • Swift, W., Gates, P., & Dillon, P. (2005). Survey of Australians using cannabis for medical purposes. Harm Reduction Journal, 2, 18–28.
  • Taylor, D. R., Poulton, R., Moffitt, T. E., Ramankutty, P., & Sears, M. R. (2000). The respiratory effects of cannabis dependence in young adults. Addiction, 98, 1669–1677.
  • Tetrault, J. M., Crothers, K., Moore, B. A., Mehra, R., Concato, J., & Fiellin, D. A. (2007). Effects of marijuana smoking on pulmonary function and respiratory complications. Archives of Internal Medicine, 167, 221–228.
  • Tjepkema, M. (2004). Use of cannabis and other illicit drugs. Health Reports, 15(4), 41–47.
  • Tramer, M. R., Carroll, D., Campbell, F., Reynolds, D. J. M., Moore, A., & McQuay, H. J. (2001). Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. British Medical Journal, 323, 1–8.
  • Ware, M. A., Adams, H., & Guy, G. W. (2005). The medicinal use of cannabis in the UK: Results of a nationwide survey. International Journal of Clinical Practice, 59(3), 291–295.
  • Ware, M. A., Rueda, S., Singer, J., & Kilby, D. (2003). Cannabis use by persons living with HIV/AIDS: Patterns and prevalence of use. Journal of Cannabis Therapeutics, 3(2), 3–15.
  • Women's Health Bureau. (2003). Exploring concepts of gender and health. Ottawa, ON: Health Canada. Retrieved February 14, 2010, from the World Wide Web: http://www.hc-sc.gc.ca/hl-vs/alt_formats/hpb-dgps/pdf/exploring_concepts.pdf
  • World Health Organisation. (2007). Gender and tobacco control: A policy brief. Geneva, Switzerland: Department of Gender, Women and Health, World Health Organization. Retrieved June 20, 2010, from the World Wide Web: http://extranet.who.int/iris/bitstream/123456789/982/1/9789241595 773_eng.pdf
  • Zajicek, J., Fox, P., Sanders, H., Wright, D., Vickery, J., Nunn, A., (2003). Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): Multicentre randomised placebo-controlled trial. The Lancet, 362, 1517–1526.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.